CALL US:022-2204 0015 / 16 / 17
Shanghai August 14 , 2017
The first-ever China Pharma Environmental Forum was an integral feature of the 2017 edition of CPhI and its co-located event, P-MEC China, which concluded at the Shanghai New International Expo Centrein Shanghai recently.

They were co-organised by UBM EMEA, UBM Sinoexpo and the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE).

The events reported a positive outlook for the further development of the Chinese pharmaceutical market.

Since 2016, CPhI China has experienced a 14 per cent increase in overall visits and a 12 per cent growth in overseas visits – a remarkable achievement for a mature market with 17 previous editions behind it.

The event, which featuredover 2,800 exhibiting companies covering the entire supply chain, acts as an accurate barometer of the industry’s overall growth patterns and future developments.

Two major trends that emerged from Asia’s largest pharma event were the increased interest and the promotion of intelligent manufacturing systems and green manufacturing approaches.

While the former emphasised a rapid shift within China’s industry towards advanced facilities and product classes, the latter was a particularly notable change in light of the country’s general reputation.

Asia’s influential pharmaceutical trading platform

Another major development in 2017 was the introduction of the first edition of the CPhI China Pharma Week, which was a direct responseto China’s increased internationalisation.

Throughout the week, CPhI and P-MEC China attendees had the opportunity to experience richer content than they did in any other previous edition.

To mention a few, there were plant visits to leading research and development (R&D) and innovation companies;the CPhI China River Cruise Networking dinner on Huangpu River (that was attended by over 250 overseas and domestic attendees), the CPhI Pharma Business International Programme to help overseas companies solve problems they encounter when entering the Chinese market and many more.
Activities at China Pharma Week

As part of the CPhI China Pharma week, the show saw the launch of the Bluebook on Internationalisation of China’s Pharmaceutical Industry (which listed the largest Chinese companies operating internationally).

Another highlight was the 2017 Awards for Top 100 Internationalised Pharmaceutical Companies in China.

Both were influential regional lists that reviewed and documented the country’s most prominent companies.

Finally, 2017 saw the arrival of another global trend sweeping through the pharma industry, with the first-ever CPhI Women in Leadership Forum in China.

It featured high-level debates on how to advance female executive potential, thereby contributing to the fast development of the pharmaceutical industry in the country.

In total, 55,020 visits were recorded over the three-day event, with 10,126 visits from international attendees, including representatives from over 120 countries.

The exhibition coverws an enormous area of 165,000sq m, which made it the biggest edition of CPhI and P-MEC China to date.

Rutger Oudejans, brand director, pharma, UBM, said, “CPhI China has grown to be the single most influential meeting point for pharma suppliers and customers, and this year we observed a record number of international attendees and over 55,000 visits in total.”

“The pharma economy has diversified rapidly in the last few years, and new markets are emerging in bio and final dosage forms. This is in addition to the ingredients sector, which represents about 40 per cent of the global production,” he added.

“This year’s event was especially significant, as we increased the range of insights and analysis across the changing business and regulatory environment,” Oudejans said.

“There were sessions held on everything, from the MAH pilot to formulation development strategies and international distribution,” he added.

“Next year, we expect even stronger growth as the domestic pharma economy cements its number two status and exports of new forms grow exponentially,” Oudejans said.

CPhI and P-MEC China will return with its 18th edition in 2018. The event will be held, alongside the second essay of the CPhI China Pharma Week, at the Shanghai New International Expo Centre between June 20 and 22, 2018.


Share This Story

Leave a Reply
Your name (required)   Your email (required)
Website (required)
Enter Code (Required)





India needs to align with global good practices to reinvogorate its capability in pharmaceutical manufacture. The regula ...


About Us
Contact Us
News Archives

Product Finder
Features and Articles
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
Media Information
Rate Card
Copyright © 2013 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Internet Explorer(9.0) or Firefox(26.0)